The Online Investor
Inhibikase Therapeutics Inc (IKT)

Inhibikase Therapeutics is a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Co.'s multi-therapeutic pipeline has a primary focus on neurodegeneration and its primary program utilizing IkT-148009, c-Abl inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases. Co. is also developing platform technologies for alternate ways to deliver protein kinase inhibitors in patients.
Company Name: 
Inhibikase Therapeutics Inc
Website: 
www.inhibikase.com
Sector: 
Biotechnology
Number of ETFs Holding IKT: 
1
Total Market Value Held by ETFs: 
$35367
Total Market Capitalization: 
$14.00M
% of Market Cap. Held by ETFs: 
0.25%
Quotes delayed 20 minutes

Email EnvelopeFree IKT Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
89th percentile
(ranked higher than approx. 89% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Inhibikase Therapeutics Inc (IKT) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.